Ewa Fiorentino Rozek: APS – When “Unprovoked” Clots And Pregnancy Loss Connect
Ewa Fiorentino Rozek, Head of Clinical Affairs at AliveDx, shared on LinkedIn:
‘‘Antiphospholipid Syndrome (APS): when “unprovoked” clots and pregnancy loss connect
What it is: An autoimmune pro-thrombotic state causing venous/arterial thromboses and pregnancy morbidity.
It can be primary or overlap with SLE.
Patients often appear “too young” for DVT/PE or stroke; recurrent miscarriage may be the first clue.
Clinical clues: unprovoked DVT/PE, stroke/TIA under 50, livedo reticularis, thrombocytopenia, recurrent early losses or late complications in pregnancy.
Management changes dramatically if APS is confirmed—anticoagulation choices and obstetric planning differ.
Diagnostics (snapshot):
– Antibodies: anticardiolipin (aCL) and anti-β2GPI (IgG/IgM).
– Functional: lupus anticoagulant (LA).
– Key principle: persistence—positive results repeated after ~12 weeks to confirm.”
Stay updated with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp